Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study (Q81570219)
scientific article published on 02 December 2005
Language:
(P31) (Q13442814)
(P304) 436-440
(P433) 3
(P478) 101
(P577) Friday, December 2, 2005
(P921) (Q42824440)
(Q880)
(Q5625186)
(Q423762)
(P1433) (Q5625182)
(P1476) "Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study" (language: en)
(P2093) Gynecologic Oncology Group
Maurie Markman
John Blessing
Stephen C Rubin
Joseph Connor
Parviz Hanjani
Steven Waggoner
(P2860) (Q69372459)
(Q54196081)
(Q33490795)
(Q33856411)
(Q71975333)
(Q53972578)
(Q48035637)
(Q54254497)
(Q72880127)
(Q34142103)
(Q40675277)
(Q27860681)
(Q40673230)
(Q47799946)
(Q34723890)
other details
description scientific article published on 02 December 2005

External Links